Schering-Plough Corp.

Related Content

Technology
Drug Attacks Cholesterol In Two Ways

Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called ...

Home March 10, 2010
arrow
Technology
Drug Offers Different Way to Fight Cholesterol

Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to ...

Home March 10, 2010
arrow
News
Drug Company Files Cholesterol Medication Patent Challenge

December 22, 2009 – A drug manufacturer recently filed paperwork with the FDA to produce a generic version of the ...

Home December 22, 2009
arrow
News
Merck, Schering-Plough Resolve Civil Class-Action Lawsuits Related to VYTORIN, ZETIA

August 6, 2009 – Merck & Co. Schering-Plough Corp. and the companies' cholesterol joint venture, Merck/Schering-Plough ...

Home August 06, 2009
arrow
News
ZETIA, VYTORIN Makers Merck, Schering-Plough Merge in $41.1 Billion Deal

March 9, 2009 – Merck & Co. Inc. and Schering-Plough Corp. today said their Boards of Directors unanimously approved a ...

Home March 09, 2009
arrow
News
Cholesterol-Lowering Drugs Decrease Coronary Artery Disease, But Not Aortic Valve Disease

July 23, 2008 – A recent study found intensive LDL-cholesterol lowering with the combination of the drugs simvastatin ...

Home July 22, 2008
arrow
News
Schering-Plough Plans Phase III of Antiplatelet Clinical Trials

April 19, 2007 — Schering-Plough Corp. has announced plans to initiate two global Phase III large-scale clinical ...

Home April 18, 2007
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now